CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4 | -99.9% | 33,185 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | -25.0% | 33,185 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -55.6% | 33,185 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $18,000 | -10.0% | 33,185 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | -41.2% | 33,185 | 0.0% | 0.00% | -60.0% |
| Q3 2021 | $34,000 | -44.3% | 33,185 | 0.0% | 0.01% | -44.4% |
| Q2 2021 | $61,000 | – | 33,185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |